Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Cigna Group (NYSE: CI) closed at $300.32 down -0.15% from its previous closing price of $300.76. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 2.49 million shares were traded. CI stock price reached its highest trading level at $301.11 during the session, while it also had its lowest trading level at $297.945.
Ratios:
For a deeper understanding of Cigna Group’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.66.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $388.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $388 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’25 when Jones Nicole S sold 28,526 shares for $300.00 per share. The transaction valued at 8,557,800 led to the insider holds 25,648 shares of the business.
Jones Nicole S bought 28,526 shares of CI for $8,557,800 on Aug 15 ’25. On Aug 12 ’25, another insider, Eder Noelle K, who serves as the Former Officer of the company, bought 35,711 shares for $275.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 80163815424 and an Enterprise Value of 106005839872. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.40, and their Forward P/E ratio for the next fiscal year is 9.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 1.99. Its current Enterprise Value per Revenue stands at 0.405 whereas that against EBITDA is 9.292.
Stock Price History:
The Beta on a monthly basis for CI is 0.49, which has changed by -0.16095328 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $370.83, while it has fallen to a 52-week low of $256.89. The 50-Day Moving Average of the stock is -0.01%, while the 200-Day Moving Average is calculated to be -2.57%.
Shares Statistics:
For the past three months, CI has traded an average of 1.87M shares per day and 1701600 over the past ten days. A total of 266.60M shares are outstanding, with a floating share count of 262.90M. Insiders hold about 1.51% of the company’s shares, while institutions hold 89.92% stake in the company. Shares short for CI as of 1755216000 were 3316471 with a Short Ratio of 1.31, compared to 1752537600 on 2882831. Therefore, it implies a Short% of Shares Outstanding of 3316471 and a Short% of Float of 1.6500000000000001.
Dividends & Splits
According to the company, the forward annual dividend rate for CI is 5.82, from 5.82 in the trailing year. Against a Trailing Annual Dividend Yield of 0.019350978The stock’s 5-year Average Dividend Yield is 1.34. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-06-03 with an ex-dividend date of 2025-09-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
The market rating of Cigna Group (CI) is currently shaped by the ongoing analysis conducted by 22.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $8.05, with high estimates of $8.47 and low estimates of $7.48.
Analysts are recommending an EPS of between $29.86 and $29.23 for the fiscal current year, implying an average EPS of $29.66. EPS for the following year is $33.02, with 24.0 analysts recommending between $34.0 and $32.07.
Revenue Estimates
A total of 11 analysts believe the company’s revenue will be $67.03B this quarter.It ranges from a high estimate of $68.59B to a low estimate of $64.85B. As of the current estimate, Cigna Group’s year-ago sales were $63.69BFor the next quarter, 11 analysts are estimating revenue of $68.05B. There is a high estimate of $70.44B for the next quarter, whereas the lowest estimate is $65.6B.
A total of 18 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $271.25B, while the lowest revenue estimate was $253.07B, resulting in an average revenue estimate of $263.3B. In the same quarter a year ago, actual revenue was $247.1BBased on 17 analysts’ estimates, the company’s revenue will be $274.3B in the next fiscal year. The high estimate is $289.14B and the low estimate is $261.94B.
